CMS lays out plans for negotiating drug prices

CMS lays out plans for negotiating drug prices

Source: 
BioPharma Dive
snippet: 

The Centers for Medicare and Medicaid Services on Wednesday released initial guidance for how it plans to negotiate prices for drugs under Medicare, a power granted to the agency by last year’s Inflation Reduction Act.